Research Fellowship 2008 - Jackson

Grant number: 508950 | Funding period: 2008 - 2012

Completed

Abstract

I am an immunologist with a background in virology and peptide chemistry and my work is therefore inter-disciplinary but focused on the design of synthetic, epitope-based vaccines against infectious agents particularly influenza and hepatitis C viruses an

Related publications (4)

Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus

R Chin, L Earnest-Silviera, CL Gordon, K Olsen, I Barr, LE Brown, DC Jackson, J Torresi

2013-01-01

Background: Infection with pandemic A/H1N1/2009 influenza virus led to hospitalisation of patients not expected to be at risk of s..

Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses

BY Chua, D Johnson, A Tan, L Earnest-Silveira, T Sekiya, R Chin, J Torresi, DC Jackson

2012-10-16

Although many studies provide strong evidence supporting the development of HCV virus-like particle (VLP)-based vaccines, the fact..

Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals

S Li, S Roberts, M Plebanski, M Gouillou, T Spelman, P Latour, D Jackson, L Brown, RL Sparrow, HM Prince, D Hart, BE Loveland, EJ Gowans

2012-08-14

We have previously reported a world-first phase I clinical trial to treat HCV patients using monocyte-derived dendritic cells (Mo-..

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody

D Pejoski, W Zeng, S Rockman, LE Brown, DC Jackson

2010-07-01

A conserved 15 amino-acid residue sequence of the ectodomain of the M2 protein of influenza A virus (M2e) induces a strong antibod..

University of Melbourne Researchers

David Jackson